As the global economy mends, the 2021 growth of Rapid Antigen Testing (RAT) for COVID-19 will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Antigen Testing (RAT) for COVID-19 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Antigen Testing (RAT) for COVID-19 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Rapid Antigen Testing (RAT) for COVID-19 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Rapid Antigen Testing (RAT) for COVID-19 market, reaching US$ million by the year 2028. As for the Europe Rapid Antigen Testing (RAT) for COVID-19 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Rapid Antigen Testing (RAT) for COVID-19 players cover Abbott, Quidel, ACCESS BIO, and CTK Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antigen Testing (RAT) for COVID-19 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Community Testing
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology